TD Cowen Lowers Oracle (NYSE:ORCL) Price Target to $240.00

Oracle (NYSE:ORCL) had its target price lowered by equities researchers at TD Cowen from $300.00 to $240.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the enterprise software provider’s stock. TD Cowen’s price target indicates a potential upside of 66.70% from the stock’s current price.

Other research analysts also recently issued reports about the company. CLSA started coverage on Oracle in a report on Monday, July 20th. They issued a “hold” rating and a $145.00 price target on the stock. DA Davidson upped their price objective on Oracle from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Thursday, June 11th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $190.00 price objective on shares of Oracle in a research report on Thursday, June 11th. Sanford C. Bernstein lifted their target price on Oracle from $319.00 to $325.00 and gave the company an “outperform” rating in a research note on Thursday, June 11th. Finally, Evercore reiterated an “outperform” rating and issued a $245.00 target price on shares of Oracle in a report on Monday, June 8th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $262.39.

Oracle Stock Performance

Shares of Oracle stock opened at $143.97 on Tuesday. The firm has a market cap of $414.71 billion, a P/E ratio of 24.74, a P/E/G ratio of 0.94 and a beta of 1.72. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 3.21. Oracle has a 12 month low of $114.50 and a 12 month high of $345.72. The stock’s fifty day moving average price is $140.21 and its 200-day moving average price is $160.55.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.15. The company had revenue of $19.18 billion for the quarter, compared to analyst estimates of $19.10 billion. Oracle had a net margin of 25.37% and a return on equity of 58.62%. Oracle’s revenue was up 20.6% compared to the same quarter last year. During the same period last year, the company posted $1.70 earnings per share. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. On average, equities research analysts expect that Oracle will post 6.49 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Vice Chairman Jeffrey Henley sold 400,000 shares of the business’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the sale, the insider owned 400,000 shares in the company, valued at approximately $63,664,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 40.90% of the company’s stock.

Institutional Investors Weigh In On Oracle

Large investors have recently made changes to their positions in the stock. Cornerstone Financial Management LLC increased its position in shares of Oracle by 65.1% in the 2nd quarter. Cornerstone Financial Management LLC now owns 279 shares of the enterprise software provider’s stock valued at $41,000 after acquiring an additional 110 shares during the period. Corient Private Wealth LP lifted its position in Oracle by 7.1% during the 2nd quarter. Corient Private Wealth LP now owns 1,282,773 shares of the enterprise software provider’s stock worth $187,991,000 after acquiring an additional 85,347 shares during the period. Formuepleje A S purchased a new stake in Oracle during the 2nd quarter valued at about $1,358,000. Amundi grew its stake in Oracle by 1.5% during the 2nd quarter. Amundi now owns 9,878,184 shares of the enterprise software provider’s stock valued at $1,447,648,000 after purchasing an additional 144,087 shares during the last quarter. Finally, Wellington Grp LLC increased its holdings in shares of Oracle by 15.1% in the second quarter. Wellington Grp LLC now owns 22,036 shares of the enterprise software provider’s stock valued at $3,229,000 after purchasing an additional 2,886 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle reported approximately $638 billion in remaining performance obligations at fiscal 2026 year-end, up 363% year over year. The backlog exceeds the company’s roughly $430 billion market value, and management expects 12% to convert to revenue within 12 months, supporting the long-term growth outlook. Oracle Has $638 Billion of Contracted Backlog and a $430 Billion Stock
• Positive Sentiment: Oracle’s healthcare AI expansion—including tools for automated coding, dictation and chart review—could deepen its position in mission-critical healthcare workflows and increase demand for its broader cloud platform. Is Oracle Using Healthcare AI to Quietly Redefine Its Core Cloud Strategy?
• Neutral Sentiment: Oracle is expected to report earnings Tuesday, making the release a near-term catalyst. Investors will focus on cloud growth, AI-related bookings, capital expenditures and whether contracted backlog is converting into revenue. Oracle Projected to Post Earnings on Tuesday
• Negative Sentiment: Higher interest rates are weighing on technology valuations, while Oracle is trading near an important technical area after a broad retreat from last year’s highs. Microsoft, Apple and Oracle Face Rising Rate Pressure
• Negative Sentiment: Critics argue Oracle’s AI buildout requires major spending before the associated revenue arrives, potentially pressuring free cash flow and returns even with record bookings. The Bill for Oracle’s AI Build Arrived Before the Revenue
• Negative Sentiment: A prominent investor reportedly advised against buying Oracle stock, reflecting concerns that the shares may remain an underperformer despite the company’s large AI opportunity. Don’t Do It, Says Top Investor About Oracle Stock

Oracle Company Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.